P-ISSN 2575-3819
E-ISSN 2575-3827
Vol. 21, Issue 2, 2014January 01, 2014 EDT
Novartis Ag v. Union of India: “Evergreening,” Trips, and “Enhanced Efficacy” Under Section 3(d)
Novartis Ag v. Union of India: “Evergreening,” Trips, and “Enhanced Efficacy” Under Section 3(d)
Dorothy Du,
Novartis AG v. Union of Indiapharmaceutical industrysecondary patentsIndian Patent ActsevergreeningTrade-Related Aspects of Intellectual Property RightsTRIPSWorld Trade OrganizationIntellectual Property Appellate Boardimatinib mesylateinventive stepnoveltyenhanced efficacydoctrine of inherent anticipationdouble patentingprior art
Articles in Vol. 21, Issue 2, 2014
Vol. 21, Issue 2, 2014
- Novartis Ag v. Union of India: "Evergreening," Trips, and "Enhanced Efficacy" Under Section 3(d)Dorothy Du
- Gray Works: How the Failure of Copyright Law to Keep Pace with Technological Advancement in the Digital Age Has Created a Class of Works Whose Protection is Uncertain… and What Can Be Done About ItKenneth R.L. Parker
- Fonts, Typefaces, and IP Protection: Getting to Just RightEmily N. Evans
- The Integrated Approach: A Solution to Patent Subject Matter Eligibility Standards in the Software ContextCarrie Moss
- Saving the Next Superman: An Alternative Approach to the Taxation of Copyright Termination RightsBenjamin Newell
Dorothy Du, Novartis Ag v. Union of India: “Evergreening,” Trips, and “Enhanced Efficacy” Under Section 3(d), 21 Ga J.L. & Tech. 223 (2014).